Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Skin Cancer Therapy
Recent news which mentions Skin Cancer Therapy
Latest study demonstrates high efficacy in curing invasive non-melanoma skin cancer
October 25, 2023
Tags
Biotech
Non/melanoma skin cancer
Medical
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Basal Cell Carcinoma
Marketing
Squamous Cell Carcinoma
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Non/melanoma skin cancer
Painless
OncoBeta GmbH
From
PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
December 22, 2022
Tags
OncoBeta GmbH
Non/melanoma skin cancer
Medical
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Bavaria
Medical
Science
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Rhenium/188
EPIC/Skin
Rostock
From
PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
Rhenium/SCT
Munich
Beauty
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Basal Cell Carcinoma
Rhenium/SCT
Munich
From
PRLog
Austrian skin cancer patients take part in EPIC-Skin clinical study
March 15, 2022
Tags
Austria
Basal Cell Carcinoma
Rhenium/SCT
From
PRLog
First Patients Registered Into OncoBeta's International Registry For Non-Melanoma Skin Cancer Treatments
February 14, 2022
Tags
International Registry
Basal Cell Carcinoma
Skin Cancer Treatment
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Australia
Rhenium/188
Basal Cell Carcinoma
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Gauteng
Painless
Non/melanoma skin cancer
From
PRLog
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer
September 09, 2021
Tags
Science
Medical
Aesthetic
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
Sydney
NMSC therapy
Skin Cancer Therapy
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today